FDA
-
-
-
-
-
-
-
BD gains FDA clearance for multi-modality breast biopsy system
-
-
-
-
-
-
-
BD Reports Third Quarter Fiscal 2025 Financial Results
-
-
-
-
-
-
-
Becton Dickinson (BDX) Launches Bioabsorbable Mesh Designed for Umbilical Hernia Repair
-
-
-
-
-
-
-
New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
-
-
-
-
-
-
-
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
-
-
-
-
-
-
-
Becton Dickinson (BDX) Increases Domestic Production
-
-
-
-
-
-
-
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
-
322,206 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

